EFBA Pharma Journal https://efbapharma.ph/blog/ Regulation and science for licensed suppliers. en-PH Tue, 03 Nov 2026 02:00:00 +0000 https://efbapharma.ph/assets/img/blog/fda-lto-cpr-import-injectables-philippines-cover.webp EFBA Pharma Journal https://efbapharma.ph/blog/ Importing injectable products into the Philippines: Food and Drug Administration (FDA) License to Operate (LTO) and Certificate of Product Registration (CPR) for foreign manufacturers and local distributors https://efbapharma.ph/blog/fda-lto-cpr-import-injectables-philippines/ https://efbapharma.ph/blog/fda-lto-cpr-import-injectables-philippines/ Tue, 03 Nov 2026 02:00:00 +0000 Regulation The two documents the Philippines asks for, who may hold each, what the dossier for an imported product contains, and where a foreign manufacturer fits beside a local License to Operate holder. How Philippine hospitals and licensed facilities can verify an injectable supplier: Food and Drug Administration (FDA) verification portal, Certificate of Product Registration (CPR) number, License to Operate (LTO), authorization letter and batch documents https://efbapharma.ph/blog/verify-injectable-supplier-philippines/ https://efbapharma.ph/blog/verify-injectable-supplier-philippines/ Tue, 03 Nov 2026 01:30:00 +0000 Procurement A checklist in five layers for hospital procurement and pharmacy staff: the supplier's license, the product registration, the link between them, batch documents and storage records. NAD+ and intravenous administration: what the research shows and does not show https://efbapharma.ph/blog/nad-plus-research-evidence-intravenous/ https://efbapharma.ph/blog/nad-plus-research-evidence-intravenous/ Tue, 03 Nov 2026 01:00:00 +0000 Molecule science How cells make and consume NAD+, what trials of the precursors NR and NMN measured, and what the small published literature on intravenous NAD+ does and does not establish.